Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Episurf Medical

0.04 SEK

Less than 1K followers

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-2.89 %
-10.65 %
-0.54 %
+23.41 %
-23.12 %
-49.94 %
-96.97 %
-98.06 %
-98.98 %

Episurf Medical operates in the medical technology industry and focuses on the development and manufacture of individually adapted implants for joint repair. The company's products are aimed at surgeons and healthcare institutions. The business is global with a main presence in Europe, North America and Asia. Episurf Medical was founded in 2008 and is headquartered in Stockholm, Sweden.

Read more
Market cap
103.71M SEK
Turnover
-
Revenue
13.5M
EBIT %
-428.89 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10/4
2026

General meeting '26

24/4
2026

Interim report Q1'26

24/8
2026

Interim report Q2'26

All
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release2/27/2026, 10:45 AM

Förändring av antalet aktier och röster i Episurf Medical

Episurf Medical
Regulatory press release2/27/2026, 10:45 AM

Change in number of shares and votes in Episurf Medical

Episurf Medical
Press release2/25/2026, 7:30 AM

New US patent approval for Episurf Medical

Episurf Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/25/2026, 7:30 AM

Nytt patentbeviljande i USA för Episurf Medical

Episurf Medical
Regulatory press release2/24/2026, 9:15 AM

Episurfs styrelse har beslutat om nyemission av B-aktier, konvertibler och teckningsoptioner som en del av vederlaget för förvärv av fastighetstillgångar

Episurf Medical
Regulatory press release2/24/2026, 9:15 AM

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets

Episurf Medical
Regulatory press release2/23/2026, 3:15 PM

Episurf Medical AB announces outcome of exercise of warrants of series TO14 B

Episurf Medical
Regulatory press release2/23/2026, 3:15 PM

Episurf Medical AB offentliggör utfall för nyttjandet av teckningsoptioner av serie TO14 B

Episurf Medical
Regulatory press release2/23/2026, 7:30 AM

Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026

Episurf Medical
Regulatory press release2/23/2026, 7:30 AM

Valberedningens ledamöter inför Episurf Medicals årsstämma 2026

Episurf Medical
Regulatory press release2/19/2026, 12:42 PM

Finansinspektionen: Flaggningsmeddelande i Episurf Medical AB

Episurf Medical
Regulatory press release2/10/2026, 9:40 AM

Episurf Medical meddelar ledningsförändringar från den 11 februari 2026

Episurf Medical
Regulatory press release2/10/2026, 9:40 AM

Episurf Medical announces leadership changes effective from 11 February 2026

Episurf Medical
Regulatory press release2/10/2026, 8:55 AM

Kommuniké från extra bolagsstämma i Episurf Medical AB (publ)

Episurf Medical
Regulatory press release2/10/2026, 8:55 AM

Press release from extraordinary general meeting in Episurf Medical AB (publ)

Episurf Medical
Press release2/9/2026, 7:30 AM

Nyttjandeperioden för teckningsoptioner av serie TO14 B i Episurf inleds idag

Episurf Medical
Press release2/9/2026, 7:30 AM

The exercise period for warrants of series TO14 B in Episurf commences today

Episurf Medical
Regulatory press release2/6/2026, 7:30 AM

Episurf: BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2025

Episurf Medical
Regulatory press release2/6/2026, 7:30 AM

Episurf: YEAR-END REPORT 1 JANUARY - 31 DECEMBER 2025

Episurf Medical
Regulatory press release1/27/2026, 9:07 AM

Finansinspektionen: Flaggningsmeddelande i Episurf Medical AB

Episurf Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.